Company Monitoring Page for Takeda

latest headlines for company on cafepharma

Takeda Eyes 12 New Drug Approvals by 2024, Hemophilia Gene Therapy May Not be a Competitor
BioSpace
Wed, 01/22/20 - 11:08 am
Tags:
Takeda, drug approvals, hemophilia A, TAK-754, TAK-748
Charles River pens Takeda early-stage drugs deal
Fierce Biotech
Mon, 01/13/20 - 10:53 am
Tags:
JPMHC 2020, Charles River Laboratories, Takeda
Takeda to Fund AI Projects at MIT as Part of New 3-Year Collaboration
Xconomy
Tue, 01/7/20 - 10:50 am
Tags:
Takeda, MIT, artificial intelligence
Drugmakers rebranding around oncology, rare diseases could provide 2020 preview
Fierce Pharma
Thu, 12/19/19 - 11:32 pm
Tags:
oncology, Rare Diseases, AstraZeneca, GSK, Alexion, Takeda, Soliris
Takeda Strikes Potential $1 Billion Oncology Deal with Turnstone
BioSpace
Thu, 12/19/19 - 12:56 pm
Tags:
Takeda, Turnstone Biologics, RIVAL-01, cancer, oncology
Takeda and Cerevance Team Up to Take on GI Diseases
BioSpace
Thu, 12/19/19 - 12:08 am
Tags:
Cerevance, Takeda, gastrointestinal disease
As NASH shifts again, the focus remains on Genfit’s big readout
EP Vantage
Wed, 12/18/19 - 10:53 am
Tags:
NASH, Genfit, elafibranor, Pfizer, Boehringer Ingelheim, Gilead Sciences, Poxel, Takeda, Intercept Pharma
ASH: Takeda details Ninlaro's miss in scrapped AL amyloidosis trial
Fierce Pharma
Mon, 12/9/19 - 09:59 am
Tags:
ASH2019, Takeda, Nilaro, AL amyloidosis
Takeda's dengue vaccine efficacy slips between 12- and 18-month analyses
Fierce Pharma
Mon, 11/25/19 - 09:52 pm
Tags:
Takeda, vaccines, dengue, TAK-003
Takeda sets sights on first-line lung cancer market with new Alunbrig data
Pharmaforum
Mon, 11/25/19 - 09:49 am
Tags:
Takeda, Alunbrig, clinical trials, Pfizer, Xalkori, ALK-positive non-small cell lung cancer
Takeda eyes Alunbrig earlier lung cancer use as 2-year data trounce Pfizer’s Xalkori
Fierce Pharma
Sat, 11/23/19 - 04:12 pm
Tags:
Pfizer, Xalkori, ALK-positive non-small cell lung cancer, Takeda, Alunbrig
Takeda sees cell, gene therapy in its future. Is it too late?
Biopharma Dive
Thu, 11/21/19 - 10:16 am
Tags:
Takeda, gene therapy, Rare Diseases
Takeda doubles down on Finch's microbiome insights, signing up for a second project in Crohn's disease
Endpoints
Wed, 11/13/19 - 11:22 pm
Tags:
Takeda, Finch Therapeutics, microbiome, Crohn's Disease
Orphan Drug Recall Leaves Patients in the Lurch
RAPS.org
Mon, 11/11/19 - 10:43 am
Tags:
hypoparathyroidism, patients, product recalls, Takeda, Natpara
Takeda scores a win for Ninlaro as it aims to pioneer 'switch' maintenance in multiple myeloma
Fierce Pharma
Fri, 11/8/19 - 10:57 am
Tags:
Takeda, Ninlaro, Multiple Myeloma, clinical trials
Early data on Takeda's dengue vaccine is promising, but wait for the full dataset
Endpoints
Thu, 11/7/19 - 10:55 pm
Tags:
Takeda, vaccines, dengue, clinical trials
Takeda's dengue shot 80% effective in massive phase 3 test
Fierce Pharma
Wed, 11/6/19 - 05:17 pm
Tags:
Takeda, dengue, vaccines, Sanofi, clinical trials
Takeda nets $660m from product selloff to Germany’s Stada
Pharmaforum
Wed, 11/6/19 - 10:33 am
Tags:
Takeda, Germany, Stada, debt
Takeda acquires TAK-101 license from COUR in $420m deal
Pharmaceutical Business Review
Wed, 10/23/19 - 10:16 am
Tags:
Takeda, COUR Pharmaceutical Development, CNP-101, TAK-101, celiac disease
Takeda pares down products and jobs, revives Genzyme building plans
Bizjournals
Fri, 10/18/19 - 09:50 am
Tags:
Takeda, Shire, M&A, layoffs

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.